Cargando…
Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
Cancer patients are at major risk of developing venous thromboembolism (VTE), resulting in increased morbidity and economic burden. While a number of theories try to explain its pathophysiology, its risk stratification can be broadly done in cancer-related, treatment–related, and patient-related fac...
Autores principales: | Qureshi, Waqas, Ali, Zeeshan, Amjad, Waseem, Alirhayim, Zaid, Farooq, Hina, Qadir, Shayan, Khalid, Fatima, Al-Mallah, Mouaz H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963402/ https://www.ncbi.nlm.nih.gov/pubmed/27517038 http://dx.doi.org/10.3389/fcvm.2016.00024 |
Ejemplares similares
-
Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017) -
Newer Oral Anticoagulant Agents: A New Era in Medicine
por: Goel, Ramil, et al.
Publicado: (2012) -
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
por: Toth, Peter P
Publicado: (2016) -
New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010) -
New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)